Fig. 5
From: Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer
Microbiome differences between responders and non-responders to chemoradiotherapy at 6 months. A NMDS plot comparing responders (R) vs non-responders (NR) after treatment. Diversity (B) and Richness (C) plots. D Phylogenetic composition at the phylum level in saliva samples based on treatment response after chemoradiotherapy. E Relative abundance of Porphyromonadaceae, Prevotellaceae, Streptococcaceae, and Fusobacteriaceae. F LEfSe analysis identifying the most differentially abundant OTUs between responders and non-responders after chemoradiotherapy. G Relative abundance of OTUs as identified by LEfSe (LDA > 3.5). H Most differentially abundant PICRUSt-predicted KEGG pathways in the salivary microbiome of responders and non-responders after chemoradiotherapy. *p < 0.05